1. Main page
  2. Biotechnology
  3. Santen Pharmaceutical

Santen Pharmaceutical

6 Decision Makers · 8 Verified Contacts

santenusa.com
📍 Emeryville, California, United StatesBiotechnology🗓 Est. 1993👥 1001–5000 employees

About Santen Pharmaceutical

Santen sells ophthalmic products.

Leadership & Decision Makers

Contact details of 6 Santen Pharmaceutical decision makers

Masahiro Inoue

Chief Administrative Officer

Akira Kurokawa

CEO

Usha Srinivasan

Senior Director, Global Regulatory Affairs

Mika Masunari

Vice President, Legal and Compliance

Naj Sharif

Executive Director, and Head Global Biomedical Sciences/ Alliances & External Research

Kenkichi Taguchi

Founder

Team & Specialists

Contact details of 2 Santen Pharmaceutical team members

Frank Binder

Global Head Supply Chain Management

Najam Sharif

VP, Global Biomedical Sciences & Strategy

General Emails

General company emails, e.g. customer support lines

    info-USA@santen.com

    Unclassified inbox

Verify Santen Pharmaceutical Emails

Similar Companies like Santen Pharmaceutical

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Vertex Pharmaceuticals

vrtx.com
Biotechnology · Boston, MA · Est. 1989 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Horizon Pharma

horizontherapeutics.com
Pharmaceuticals · Northbrook, Illinois, United States · Est. 2005 · 1001–5000 employees

HQ: Northbrook, Illinois, United States

Explore similar firms in the Biotechnology sector

Company Info

santenusa.com

+1 415 268 9100

Emeryville, California, United States

Acquired by: Unison Capital
Legal Name: Santen, Inc.
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Founded Date: 1993
Number of Exits: 3
Company Type: For Profit
Stock Symbol: OTCQX:SNPHY
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +1 415 268 9100
Last Investment Activity: Sep 16, 2020
Investments Activity: Sep 16, 2020 Sep 1, 2020 Jul 1, 2020

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.